Preclinical Imaging (In-VIVO) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2024

1
Preclinical Imaging (In-VIVO) Market Size,
Industry Analysis Report, Regional Outlook from
2017 to 2024. Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
2
Regional Analysis of Preclinical Imaging
(In-VIVO) Market

• Middle East and Africa preclinical imaging
  (In-VIVO) market share will exhibit a moderate
  growth during the forecast period. South Africa
  and Saudi Arabia are significant marketplaces in
  region accounting for rewarding growth
  opportunities.
• Several globally recognizable brands are
  available in South Africa, and there is
  continuously increasing competition from local
  players resulting in many public-private
  collaborations.
• Some of the key players operating in preclinical
  imaging (In-VIVO) market are Takara Bio, Bruker
  Biospin, Carestream Health, PerkinElmer, Evrogen,
  Agilent Technologies, BD Biosciences, Berthold
  Technologies, GE Healthcare, Hamamatsu Photonics,
  Mauna Kea Technologies, Hitachi Medical Systems,
  Thermo Fisher Scientific, LaVision, Promega, IDEX
  Health Science, Siemens Healthcare, UVP,
  LI-COR, m2m Imaging, Visage Imaging, Takeda
  Pharmaceutical Company, New England Biolabs,
  Nikon, and Koninklijke Philips.

3

• Collaboration with domestic companies, merger and
  acquisitions and new product launches are
  generally preferred policies adopted by industry
  players. For instance, Eli Lilly and Company and
  ImaginAb had a preclinical research collaboration
  to study possible novel T cell-based
  immuno-oncology treatments.
• U.S. will dominate the global revenue share owing
  to presence of established infrastructure and
  major public and private companies.
• European preclinical imaging (In-VIVO) market
  held the second largest revenue share in 2016.
  Increasing RD and favorable growth opportunities
  for players in the region will drive the region
  growth.

4
Competitive Market Share of Preclinical Imaging
(In-VIVO) Market

• Preclinical Imaging (In-VIVO) Market size will
  witness a substantial growth in the forecast
  period with rising investments for monitoring
  treatment response for early disease diagnosis
  along with cancer cell detection, bio
  distribution and drug target. Preclinical imaging
  (In-VIVO) is gradually used across several drug
  development processes, with applications ranging
  from compound optimization, to target
  identification studies. The use of preclinical
  imaging (In-VIVO) across several domains will
  boost the industry growth.
• Technological innovations such as combination of
  high resolution MRI with other imaging modalities
  should propel industry growth. The new imaging
  systems incorporate novel technologies,
  electronics, detectors, reconstruction algorithms
  and innovative software system modelling.

5

Browse Full Market Research Report On
Preclinical Imaging (In-VIVO) Market _at_
http//bit.ly/2tLKgZf Request for an in-depth
table of contents for this report _at_
http//bit.ly/2ucNzqP
6
Stay In Touch Website www.gminsights.com Soci
al Media